Osaic Holdings
CTSO icon

Osaic Holdings’s Cytosorbents Corp CTSO Stock Holding History

Osaic Holdings’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$125 – 7445
2024
Q1 		$125 Buy
+1
New +$19 ﹤0.01% 7019
2023
Q4 		– Sell
-2
Closed -$300 – 7335
2023
Q3 		$300 Sell
2
-1
-33% -$57 ﹤0.01% 7082
2023
Q2 		$3.25K Buy
3
+2
+200% +$126 ﹤0.01% 6487
2023
Q1 		$900 Buy
+1
New +$60 ﹤0.01% 6988

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's CTSO Position: Q2 2026 in Review

Osaic Holdings increased its Cytosorbents Corp (CTSO) stake by 3.4% in Q2 2026, buying an estimated $2.33K and bringing the position to 6,742 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #5493.

Osaic Holdings first reported a position in CTSO in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.54M in Q1 2022. 47 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Osaic Holdings held 6,742 shares of Cytosorbents Corp worth $50K as of Q2 2026.
  • Osaic Holdings bought 221 Cytosorbents Corp shares in Q2 2026, an estimated $2.33K.
  • Cytosorbents Corp made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5493 holding.
  • Osaic Holdings first reported a position in Cytosorbents Corp in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Cytosorbents Corp position peaked at $1.54M in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.